Products for Research Use Only
RegisterLogin

HLX43

CAT: 0804-HY-177439-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-177439-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HLX43 is an antibody-drug conjugate (ADC) targeting PD-L1. HLX43 is promising for research of PD-L1-positive solid tumors (e.g., NSCLC, head and neck cancer) [1][2].
UNSPSC
12352005
Target
Antibody-Drug Conjugates (ADCs) ; PD-1/PD-L1
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
97.73
Smiles
[HLX43]
Molecular Weight
153714 (average)
References & Citations
[1]Wang J, et al. A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX43 (anti-PD-L1 ADC) in patients with advanced/metastatic solid tumors[J]. 2025.|[2]Shan YQ, et al. Anti-pdl1 antibody-drug conjugate and use. WO2024230755A1. 2024-11-14.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
No Development Reported

Alternative Products

CatalogName
GTR18795377-01HLX43 Antibody

Popular Products